Mineralys Therapeutics Inc

NEW
NAS:MLYS (USA)  
$ 25.65 -0.10 (-0.39%) 10:08 PM EST
At Loss
P/B:
4.11
Market Cap:
$ 2.27B
Enterprise V:
$ 1.61B
Volume:
695.17K
Avg Vol (2M):
1.00M
Trade In:
Volume:
695.17K
At Loss
Avg Vol (2M):
1.00M

MLYS Stock Institutional Ownership and Insider Ownership - Mineralys Therapeutics Inc

88.41
(Mil)
Shares Outstanding
104.09%
91.77 (Mil)
Institutional Ownership
0.88%
0.77 (Mil)
Insider Ownership
83.53%
73.8467 (Mil)
Float Percentage of TSO

Short Interest History (%)

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

Institutional Ownership History (%)

This the Institutional Ownership History of Mineralys Therapeutics Inc. Peter Lynch prefers to buy companies with low institutional ownership.
* Due to varying ownership data coverage and corporate events such as splits, the information in this section is in no way guaranteed for completeness, accuracy or in any other way.

Insider ownership (%)

This is the historical insider ownership of Mineralys Therapeutics Inc. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.
1. Please note that our data vendor collects insider data for officers and directors from Forms 3,4,5 and amendments where they only capture direct ownership data, not indirect ownership.
* Due to varying ownership data coverage and corporate events such as splits, the information in this section is in no way guaranteed for completeness, accuracy or in any other way.

Top Direct Holders

Top Fund Holders